INS and type 1 diabetes mellitus: The use of nanotechnology and microdevices for T1DM therapies has been reviewed by some authors such as Ernst et al. [106], Lai et al. [107] (modular microfluidics) or Lui et al. [108] (paper-based microfluidics for glucose detection which can even be used as a telemedicine device for physicians insulin control off-site).